Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury

Experimental Neurology

Volumn 146, Issue 2, 1997, Pages 367-373

  Pan, Weihong ^a   Banks, William A ^a   Kastin, Abba J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; EBIRATIDE; SUCROSE; TUMOR NECROSIS FACTOR;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; LUMBAR SPINAL CORD; MALE; MOUSE; NERVE FIBER REGENERATION; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; SPINAL CORD INJURY;

EID: 0031214872     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6533     Document Type: Article

References (26)

1. 1. Beggs, J. L., and J. D. Waggener. 1976. Transendothelial vesicular transport of protein following compression injury to the spinal cord. Lab. Invest. 34: 428-439.
2. 2. Blight, A. R. 1992. Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9: S83-S91.
3. 3. Daniel, P. M., D. K. C. Lam, and O. E. Pratt. 1985. Comparison of the vascular permeability of the brain and the spinal cord to mannitol and inulin in rats. J. Neurochem. 45: 647-649.
4. 4. Estrada, C., C. Gomez, and C. Martin. 1995. Effects of TNFα on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture. Soc. Neurosci. Abstr. 21: 1086.
5. 5. Gutierrez, E. G., W. A. Banks, and A. J. Kastin. 1993. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47: 169-176.
6. 6. Hurwitz, A. A., W. D. Lyman, M. P. Guida, T. M. Calderon, and J. W. Berman. 1992. Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes. J. Exp. Med. 176: 1631-1636.
7. 7. Kelly, J. P. 1985. Reactions of neurons to injury. Pages 187-195 in E. R. Kandel and J. H. Schwartz, Eds., Principles of Neural Science. Elsevier, Amsterdam.
8. 8. Matsumoto, T., K. Oshima, A. Miyamoto, M. Sakurai, M. Gotoh, and S. Hayashi. 1989. Trophic action of α-melanocyte stimulating hormone (α-MSH) and Hoe 427, an adrenocorticotropic hormone (ACTH) analogue, on cultured septal neurons from rat embryos. Neurochem. Res. 14: 778. [Abstract]
9. 9. McCarron, R. M., L. Wang, M. K. Racke, D. E. McFarlin, and M. Spatz. 1993. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43: 23-30.
10. 10. Megyeri, P., C. S. Abraham, P. Temesvari, J. Kovacs, T. Vas, and C. P. Speer. 1992. Recombinant human tumor necrosis factor α constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148: 137-140.
11. 11. Noble, L. J., and D. S. Maxwell. 1983. Blood-spinal cord barrier response to transection. Exp. Neurol. 79: 188-199.
12. 12. Noble, L. J., and D. S. Maxwell. 1983. Morphometric analysis of effects of spinal cord transection. Exp. Neurol. 79: 200-211.
13. 13. Noble, L. J., and J. R. Wrathall. 1987. The blood-spinal cord barrier after injury: Pattern of vascular events proximal and distal to a transection in the rat. Brain Res. 424: 177-188.
14. 14. Pan, W., W. A. Banks, M. K. Kennedy, E. G. Gutierrez, and A. J. Kastin. 1996. Differential permeability of the BBB in acute EAE: Enhanced transport of TNF-α. Am. J. Physiol. 271: E636-E642.
15. 14C]-carboxylinulin across the blood-brain barrier and blood-spinal cord barrier in the rabbit. J. Spinal Cord Med. 18: 221-226.
16. 16. Ramon y Cajal, S. 1928. Degeneration and Regeneration of the Nervous System. Hafner, New York.
17. 4-9 analog (ebiratide) in pharmacokinetic behavior. J. Pharmacobiodyn. 13: s-86. [Abstract]
18. 18. Shimura, T., S. Tabata, T. Ohnishi, T. Terasaki, and A. Tsuji. 1991. Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier. J. Pharm. Exp. Therapeut. 258: 459-465.
19. 19. Shimura, T., S. Tabata, T. Terasaki, Y. Deguchi, and A. Tsuji. 1992. In-vivo blood-brain barrier transport of a novel adrenocorticotropic hormone analogue, ebiratide, demonstrated by brain microdialysis and capillary depletion methods. J. Pharm. Pharmacol. 44: 583-588.
20. 20. Sivron, T., M. E. Schwab, and M. Schwartz. 1994. Presence of growth inhibitors in fish optic nerve myelin: Postinjury changes. J. Comp. Neurol. 343: 237-246.
21. 21. Smith, R. A., and C. Baglioni. 1987. The active form of tumor necrosis factor is a trimer. J. Biol. Chem. 262: 6951-6954.
22. 22. Terasaki, T., S. Takakuwa, A. Saheki, S. Moritani, T. Shimura, S. Tabata, and A. Tsuji. 1992. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: Studies with monolayers of primary cultured bovine brain capillary endothelial cells. Pharm. Res. 9: 529-534.
23. 23. Tveten, L. 1976. Spinal cord vascularity. IV. The spinal cord arteries in the rat. Acta Radiol. Diagn. 17: 385-398.
24. 24. Wingfield, P., R. H. Pain, and S. Craig. 1987. Tumor necrosis factor is a compact trimer. FEBS Lett. 211: 179-184.
25. 3H]inulin after osmotic opening in the rat. Exp. Neurol. 79: 845-857.
26. 26. Ziylan, Y. Z., P. J. Robinson, and S. I. Rapoport. 1984. Blood-brain barrier permeability to sucrose and dextran after osmotic opening. Am. J. Physiol. 247: R634-R638.